INIFY Laboratories AB
OSE:INIFY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Azucar Minerals Ltd
OTC:AXDDF
|
CA |
INIFY Laboratories AB
Net Income (Common)
INIFY Laboratories AB
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
INIFY Laboratories AB
OSE:INIFY
|
Net Income (Common)
-kr67.9m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medicover AB
STO:MCOV B
|
Net Income (Common)
€77.5m
|
CAGR 3-Years
86%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Dedicare AB (publ)
STO:DEDI
|
Net Income (Common)
kr33.1m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
|
NGS Group AB
STO:NGS
|
Net Income (Common)
-kr4.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
INIFY Laboratories AB
Glance View
INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2022-06-20. The firm uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The firm origins from ContextVision.
See Also
What is INIFY Laboratories AB's Net Income (Common)?
Net Income (Common)
-67.9m
SEK
Based on the financial report for Dec 31, 2025, INIFY Laboratories AB's Net Income (Common) amounts to -67.9m SEK.
What is INIFY Laboratories AB's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-15%
Over the last year, the Net Income (Common) growth was -31%. The average annual Net Income (Common) growth rates for INIFY Laboratories AB have been -15% over the past three years .
